Teresa Gomez-Isla has specific clinical interests in Alzheimer's disease and other dementias. She sees patients with these disorders as part of clinical evaluation and care, as well as for research purposes. There is a great need to understand the mechanisms that lead to neural system collapse and impaired cognition in Alzheimer's disease and related disorders, and to find better treatments potentially able to prevent or cure this illness. Her lab focuses on the development and characterization of transgenic mouse models of Alzheimer's disease and on testing novel therapeutic strategies. She also does research on postmortem human brains from individuals with Alzheimer's disease and cognitively-intact individuals across the age spectrum searching for molecular mechanisms responsible for individual vulnerability or resilience to this type of dementia.
Teresa Gomez-Isla received her medical school training at the University Complutense, Madrid, Spain and completed her residency in neurology at the Hospital Doce de Octubre, Madrid, Spain. She then completed a clinical and research fellowship in the Memory Disorders and Alzheimer's Research Laboratory of Massachusetts General Hospital. She has subserved as Chief of the Memory Disorder's Unit at Clinica Universitaria of Navarre, Pamplona, Spain, and Hospital Santa Cruz y San Pablo, Barcelona, Spain. Dr. Gomez-Isla currently serves as the co-Director of the Memory Division at the MGH Neurology Department. She sees patients and conducts clinical research at the Massachusetts General Hospital, in addition to performing basic research at MIND.